Incidence Rates of Malignant Neoplasms of Female Genital Organs in the Cohort of Females Occupationally Exposed to Ionizing Radiation
- Autores: Rumyantseva A.V.1, Azizova T.V.1, Bannikova M.V.1
-
Afiliações:
- Southern Urals Biophysics Institute
- Edição: Volume 68, Nº 3 (2023)
- Páginas: 33-38
- Seção: Radiation Epidemiology
- URL: https://medbiosci.ru/1024-6177/article/view/363834
- DOI: https://doi.org/10.33266/1024-6177-2023-68-3-33-38
- ID: 363834
Citar
Texto integral
Resumo
Purpose: To assess the association of incidence rates of malignant neoplasms of female genital organs (MNs of FGO) in women who were chronically occupationally exposed to ionizing radiation (IR) with radiation and non-radiation factors.
Material and methods: To perform the study, the cohort of females employed at the Mayak PA during 1948–1982 and followed up until 31 December 2018 was considered. All members of the considered cohort were chronically exposed to IR.
Results: 83.6 % of females were first diagnosed with a MN of FGO at age after 50 years. More than 50 % of MNs of FGO were reported during 1991–2010. Standardized rates of MNs FGO varied with the calendar period with the highest rates observed during 1996–2005. The analysis of the variation of the standardized rates with time demonstrated a significant tendency to increase by the end of the follow-up (R²=0.67, p=0.03). The incidence rates of MNs of FGO on average increased annually by 1.0 % (95 % CI 0.3–1.6). The standardized rates of MNs of FGO were significantly higher in females who had been diagnosed with endometriosis prior to MNs of FGO. The standardized rates of MNs of FGO were significantly higher in females externally exposed to gamma-rays at uterus absorbed dose of 0.2–0.5 Gy and above 0.5 Gy compared to females who had been exposed at lower doses.
MNs of the uterine body were the most common among total MNs of FGO. More than 90 % of MNs of the uterine body were registered during menopause. The standardized rate of MNs of the uterine body in females of the study cohort was 0.37 ± 0.05. The decrease in the standardized rate of the MNs of the uterine body was observed in 1986–1995 calendar period. The spline regression analysis of the variation of the standardized rate of MNs of the uterine body demonstrated the annual increment by 0.9 % (95 % CI 0.7–2.5) on average. The analysis demonstrated a tendency of the standardized rate of MNs of the uterine body to increase in the study cohort of females (R²=0.46, p=0.16). The standardized rates of MNs of the uterine body were significantly higher in females who had been diagnosed with endometriosis prior to MNs of the uterine body. Standardized rates of MNs of the uterine body were significantly higher in females externally exposed to gamma rays at the cumulative uterus absorbed dose above 0.5 Gy compared to females exposed at lower doses.
Conclusion: MNs of FGO were associated with both known non-radiation factors (age, calendar period, endometriosis) and the cumulative uterus absorbed dose from chronic occupational exposure to ionizing radiation.
Sobre autores
A. Rumyantseva
Southern Urals Biophysics Institute
Email: clinic@subi.su
Ozyorsk, Russia
T. Azizova
Southern Urals Biophysics Institute
Email: clinic@subi.su
Ozyorsk, Russia
M. Bannikova
Southern Urals Biophysics Institute
Email: clinic@subi.su
Ozyorsk, Russia
Bibliografia
- Каприн А.Д., Старинский В.В., Петрова Г.В., Грецова О.П., Александрова Л.М. Злокачественные новообразования женских половых органов в России: ситуация и проблемы // Архив акушерства и гинекологии им. В.Ф. Снегирева. 2014. Т.1, № 2. С. 44-47.
- Одинцова И.Н., Писарева Л.Ф., Пикалова Л.В., Кудяков Л.А. Эпидемиологические аспекты основных локализаций гинекологического рака в Томской области // Сибирский онкологический журнал. 2017. Т.16, № 5. С. 48–54.
- Каприн А.Д., Старинский В.В., Шахзадова А.О. Состояние онкологической помощи населению России в 2021 году. М.: МНИОИ им. П.А. Герцена, 2022. 239 с.
- Сулейманова Н.Д. Факторы риска злокачественных новообразований женских половых органов (обзор литературы) // Вестник новых медицинских технологий. 2014. Т.21, № 1. С. 115-121. doi: 10.12737/3326.
- Чимитдоржиева Т.Н. Рак шейки матки у женщин Дальневосточного федерального округа (заболеваемость и смертность) // Опухоли женской репродуктивной системы. 2020. Т.16, № 2. С. 50-54. DOI: 10.17650 /1994 4098 2020 16 2 50 54.
- Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva: World Health Organization, 2020.
- Карелина О.Б., Артымук Н.В., Фетисова Т.И. Факторы риска рака яичника и возможные превентивные стратегии // Фундаментальная и клиническая медицина. 2018. Т.3, № 3. С. 91-96. doi: 10.23946/2500-0764-2018-3-3-91-96.
- Utada M., Brenner A.V., Preston D.L., Cologne J.B., Sakata R., Sugiama H., et al. Radiation Risk of Ovarian Cancer in Atomic Bomb Survivors: 1958-2009 // Radiation Research. 2020. V.195, No. 1. P. 60-65. doi: 10.1667/RADE-20-00170.
- Napier B.A. The Mayak Worker Dosimetry System (MWDS-2013): an Introduction to the Documentation // Radiat. Prot. Dosimetry. 2017. V.176, No. 1-2. P. 6-9. doi: 10.1093/rpd/ncx020.
- Румянцева А.В., Азизова Т.В., Пикулина М.В. Описательная характеристика и перспективы использования базы данных когорты женщин, подвергшихся профессиональному облучению // Проблемы репродукции. 2015. Т.20, №5. С. 29-37.
- Азизова Т.В., Тепляков И.И., Григорьева Е.С., Власенко Е.В., Сумина М.В., Дружинина М.Б. и др. Медико-дозиметрическая база данных «Клиника» работников ПО «Маяк» и их семей // Медицинская радиология и радиационная безопасность. 2009. Т.54, № 5. С. 26-35.
- Румянцева А.В., Азизова Т.В., Банникова М.В. Описательная характеристика злокачественных новообразований женских половых органов // Опухоли женской репродуктивной системы. 2021. Т.17, № 3. С. 79-88. doi: 10.17650/1994-4098-2021-17-3-79-88.
- Мерков А.М., Поляков Л.Е. Санитарная статистика: Пособие для врачей. М.: Атомиздат, 1975. 245 с.
- Zar J.H. Biostatistical Analysis. New Jersey: Prentice Hall, 1999. 663 p.
- Joinpoint Trend Analysis Software. URL: https://surveillance.cancer.gov/joinpoint (Accessed: 16.11.2020).
- Минаков С.Н. Заболеваемость и смертность от рака молочной железы и женских половых органов (шейки матки, тела матки, яичников) в Московской области в 2015 году // Злокачественные опухоли. 2017. Т.7, № 1. С. 67-69. doi: 10.18027/2224–5057–2017–1–67–69.
- Ярмолинская М.И., Молотков А.С., Протасова А.Э., Цыпурдеева А.А., Берлев И.В., Раскин Г.А. Рак яичника у больных эндометриозом // Онкогинекология. 2018. Т.3, № 27. С. 23-31. doi: 10.52313/22278710_2018_3_23.
- Istrate-Ofiţeru A.M., Pirici D., Niculescu M., Berceanu C., Berceanu S., Voicu N.L., et al. Clinical, Morphological and Immunohistochemical Survey in Different Types of Endometriosis // Romanian Journal of Morphology and Embryology. 2018. V.59, No. 4. P. 1133-1153.
- Capilna M.E., Szabo B., Puscasiu L., Aron T., Cosmin R. Endometriosis and Gynecological Cancer // Current Women`s Health Reviews. 2012. V.8, No. 2. P. 150-157. doi: 10.2174/157340412800194867.
- United Nations Scientific Committee on the Effects of Atomic Radiation et al. Biological Mechanisms of Radiation Actions at Low Doses. New York, NY: United Nations, 2012.
- Каприн А.Д., Старинский В.В., Петрова Г.В. Состояние онкологической помощи населению России в 2018 году.М.: МНИОИ им. П.А. Герцена, 2019. 236 с.
- Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена, 2018. 250 с
- Utada M., Brenner A.V., Preston D.L., Cologne J.B., Sakata R., Sugiyama H., et al. Radiation Risks of Uterine Cancer in Atomic Bomb Survivors: 1958-2009 // JNCI Cancer Spectrum. 2018. V.2, No. 4.P. pky081. doi: 10.1093/jncics/pky081.
- Костючек Д.Ф., Аничков Н.М., Печеникова В.А. Аденомиоз как факультативный фактор риска рака матки // Журнал акушерства и женских болезней. 2004. Т.53, № 4. С. 11-18.
- Boice J.D. Jr., Engholm G., Kleinerman R.A., Blettner M., Stovall M., Lisco H., et all. Radiation Dose and Second Cancer Risk in Patients Treated for Cancer of the Cervix // Radiation Research. 1988. V.116, No. 1. P. 3-55. doi: 10.2307/3577477.
- Sakata R., Kleinerman R.A., Mabuchi K., Stovall M., Smith S.A., Weathers R., et all. Cancer Mortality Following Radiotherapy for Benign Gynecologic Disorders // Radiation Research. 2012. V.178, No. 4. P. 266-279. doi: 10.1667/rr2845.1.
- Inskip P.D., Monson R.R., Wagoner J.K., Stovall M., Davis F.G., Kleinerman R.A., et all. Cancer Mortality Following Radium Treatment for Uterine Bleeding // Radiation Research. 1990. V.123, No. 3. P. 331-344.
- Atkinson W.D., Law D.V., Bromley K.J., Inskip H.M. Mortality of Employees of the United Kingdom Atomic Energy Authority, 1946-97 // Occupational & Environmental Medicine. 2004. V.61, No. 7. P. 577-585. doi: 10.1136/oem.2003.012443.
Arquivos suplementares
